Global Patent Index - EP 2602316 A1

EP 2602316 A1 20130612 - Compositions suitable for treatment of spinal disease, disorder or condition

Title (en)

Compositions suitable for treatment of spinal disease, disorder or condition

Title (de)

Zusammensetzungen zur Behandlung von Wirbelsäulenkrankheit, -störung oder -leiden

Title (fr)

Compositions appropriées pour le traitement de la maladie, un trouble ou un état de la moelle épinière

Publication

EP 2602316 A1 20130612 (EN)

Application

EP 13157678 A 20080829

Priority

  • US 93576707 P 20070830
  • EP 07115352 A 20070830
  • EP 08806958 A 20080829
  • EP 13157678 A 20080829

Abstract (en)

The invention relates to the use of viral inactivated-plasma cryoprecipitate concentrate (VIPCC) comprising a suitable fibronectin/fibrinogen ratio for treating a spine disease, disorder or condition such as intervertebral disc degeneration.

IPC 8 full level

A61K 35/16 (2015.01); A61K 35/54 (2006.01); A61K 35/545 (2015.01); A61L 27/36 (2006.01); A61L 27/38 (2006.01); A61L 27/54 (2006.01); C12N 5/071 (2010.01); C12N 5/077 (2010.01)

CPC (source: EP US)

A61K 35/16 (2013.01 - EP US); A61K 35/545 (2013.01 - EP US); A61K 38/1709 (2013.01 - US); A61K 38/363 (2013.01 - US); A61L 27/3616 (2013.01 - EP US); A61L 27/3804 (2013.01 - EP US); A61L 27/3856 (2013.01 - EP US); A61L 27/3878 (2013.01 - EP US); A61P 19/00 (2017.12 - EP); A61P 25/00 (2017.12 - EP); C12N 5/0655 (2013.01 - EP US); A61L 2430/38 (2013.01 - EP US); C12N 2500/84 (2013.01 - EP US)

Citation (applicant)

  • WO 9305822 A1 19930401 - OCTAPHARMA AG [CH]
  • US 5792835 A 19980811 - TSE DAPHNE C [US], et al
  • US 7125569 B2 20061024 - NUR ISRAEL [IL], et al
  • US 4377572 A 19830322 - SCHWARZ OTTO [AT], et al
  • EP 0691858 B1 19991215 - OMRIX BIOPHARM SA [BE]
  • US 2004121011 A1 20040624 - MCKERRACHER LISA [CA]
  • US 2005148512 A1 20050707 - HUNTER WILLIAM L [CA], et al
  • US 6428576 B1 20020806 - HALDIMANN DAVID [CH]
  • WO 2007089942 A2 20070809 - SPINAL RESTORATION INC [US], et al
  • WO 2006050268 A2 20060511 - SPINAL RESTORATION INC [US]
  • WO 2006050267 A2 20060511 - SPINAL RESTORATION INC [US], et al
  • WO 2007089948 A2 20070809 - SPINAL RESTORATION INC [US], et al
  • US 6468527 B2 20021022 - AUSTIN SAM L [US], et al
  • US 7235255 B2 20070626 - AUSTIN SAM L [US], et al
  • WO 2004093934 A2 20041104 - SDGI HOLDINGS INC [US], et al
  • WO 0047621 A1 20000817 - BAXTER AG [AT], et al
  • US 2006275273 A1 20061207 - SEYEDIN MITCHELL S [US], et al
  • US 2007093905 A1 20070426 - O'NEIL MICHAEL J [US], et al
  • EP 1894581 A1 20080305 - CELLCOTEC B V [NL]
  • EP 0534178 B1 20010418 - OMRIX BIOPHARM SA [BE]
  • EP 1390485 B1 20061011 - OMRIX BIOPHARM SA [BE]
  • WO 02095019 A1 20021128 - OMRIX BIOPHARM SA [BE]
  • WO 9833533 A1 19980806 - OMRIX BIOPHARM SA [BE], et al
  • US 6121232 A 20000919 - NUR ISRAEL [IL], et al
  • WO 9114439 A1 19911003 - OCTAPHARMA AG [CH]
  • US 5143838 A 19920901 - KRAUS MICHAEL [DE], et al
  • EP 0378798 B1 19940323 - OCTAPHARMA AG [CH]
  • AOTA ET AL.: "Differential effects of fibronectin fragment on proteoglycan metabolism by intervertebral disc cells: a comparison with articular chondrocytes", SPINE, vol. 30, 2005, pages 722 - 728
  • WALMSLEY R.: "The development and growth of the intervertebral disc", EDINBURGH MED J., vol. 60, 1953, pages 341 - 364
  • HUNTER ET AL.: "The notochordal cell in the nucleus pulposus: a review in the context of tissue engineering", TISSUE ENG., vol. 9, 2003, pages 667 - 677
  • RUDERT M; TILLMANN B.: "Lymph and blood supply of the human intervertebral disc. Cadaver study of correlations to discitis", ACTA ORTHOP SCAND., vol. 64, 1993, pages 37 - 40
  • BAR ET AL.: "The binding of fibrin sealant to collagen is influenced by the method of purification and the cross-linked fibrinogen- fibronectin (heteronectin) content of the 'fibrinogen' component", BLOOD COAGUL FIBRINOLYSIS., vol. 16, 2005, pages 111 - 117, XP009110474, DOI: doi:10.1097/01.mbc.0000161564.74387.12
  • JU ET AL., ENHANCED NEURITE GROWTH FROM MAMMALIAN NEURONS IN THREE-DIMENSIONAL SALMON FIBRIN GELS. BIOMATERIALS, vol. 28, 2007, pages 2097 - 2108
  • CHENG ET AL.: "Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function", SCIENCE, vol. 273, 1996, pages 510 - 513
  • GRUBER ET AL.: "Cell-based tissue engineering for the intervertebral disc: in vitro studies of human disc cell gene expression and matrix production within selected cell carriers", SPINE J., vol. 4, 2004, pages 44 - 55
  • FURTMÜLLER ET AL.: "Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma- aminobutyric acid(A) receptor antagonistic effect", J PHARMACOL EXP THER., vol. 301, 2002, pages 168 - 173
  • ROGER ET AL.: "Evaluating the differences between fibrin sealants: recommendations from an international advisory panel of hospital pharmacists", THE EUROPEAN JOURNAL OF HOSPITAL PHARMACY SCIENCE, vol. 12, no. 1, 2006, pages 3 - 9
  • FURTMULLER ET AL.: "Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma- aminobutyric acid(A) receptor antagonistic effect", J PHARMACOL EXP THER., vol. 301, 2002, pages 168 - 173
  • SACHS ET AL.: "Dallas discogram description. A new classification of CT/discography in low-back disorders", SPINE, vol. 12, 1987, pages 287 - 294
  • BENYA; SHAFFER: "Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels", CELL, vol. 30, 1982, pages 215 - 224, XP023910487, DOI: doi:10.1016/0092-8674(82)90027-7
  • MIEKKA ET AL.: "Rapid methods for isolation of human plasma fibronectin", THROMB RES., vol. 27, 1982, pages 1 - 14, XP022880720, DOI: doi:10.1016/0049-3848(82)90272-9
  • HAUDENSCHILD ET AL.: "Differential expression of multiple genes during articular chondrocyte redifferentiation", ANAT REC., vol. 263, 2001, pages 91 - 98
  • LI ET AL.: "Chondrocyte phenotype in engineered fibrous matrix is regulated by fiber size", TISSUE ENG., vol. 12, 2006, pages 1775 - 1785
  • PERETTI ET AL.: "A biomechanical analysis of an engineered cell- scaffold implant for cartilage repair", ANN PLAST SURG., vol. 46, 2001, pages 533 - 537, XP008049897, DOI: doi:10.1097/00000637-200105000-00013
  • REVELL ET AL.: "Tissue engineered intervertebral disc repair in the pig using injectable polymers", J MATER SCI MATER MED., vol. 18, 2007, pages 303 - 308, XP019481256, DOI: doi:10.1007/s10856-006-0693-6

Citation (search report)

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

DOCDB simple family (publication)

EP 2034010 A1 20090311; AU 2008291817 A1 20090305; BR PI0816175 A2 20150224; CN 101827617 A 20100908; CN 101827617 B 20140402; EP 2195038 A1 20100616; EP 2195038 B1 20180516; EP 2602316 A1 20130612; EP 2602316 B1 20160921; ES 2606858 T3 20170328; ES 2672151 T3 20180612; IL 204109 A 20140630; IL 232619 A0 20140630; JP 2010537968 A 20101209; US 2010310524 A1 20101209; US 2015196596 A1 20150716; US 8968724 B2 20150303; US 9326998 B2 20160503; WO 2009027814 A1 20090305

DOCDB simple family (application)

EP 07115352 A 20070830; AU 2008291817 A 20080829; BR PI0816175 A 20080829; CN 200880111955 A 20080829; EP 08806958 A 20080829; EP 13157678 A 20080829; ES 08806958 T 20080829; ES 13157678 T 20080829; IB 2008002259 W 20080829; IL 20410910 A 20100223; IL 23261914 A 20140514; JP 2010522467 A 20080829; US 201514591097 A 20150107; US 67523408 A 20080829